Eric S Schweiger, MD
- ASSISTANT CLINICAL PROFESSOR | Dermatology
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Schweiger received his medical degree at the Albert Einstein College of Medicine in New York City and did his post-doctoral training at New York University and University of Kansas Medical Center, where he served as chief dermatology resident. Dr. Schweiger currently serves as Assistant Clinical Professor of Dermatology at Mount Sinai Medical School in New York City.
Dr. Schweiger specializes in cosmetic dermatology, with a focus on laser therapy, injectables and the treatment of acne and acne scars. His clinical studies and peer-reviewed articles have been published in many journals, including Journal of Drugs and Dermatology, Journal of Cosmetic and Laser Therapy and Journal of the Academy of Dermatology. Dr. Schweiger pioneered an advanced method of treating acne scars called Focal Acne Scar Treatment (F.A.S.T.) using the fractional CO2laser at an increased energy level on areas of acne scarring. His findings were published in Journal of Drugs in Dermatology in 2013 and have since received much acclaim and attention. Acne scar patients from around the globe continue to seek out Dr. Schweiger for F.A.S.T.
Dr. Schweiger started Schweiger Dermatology Group in 2010 with one office and a single employee and has since grown the practice to over 20 offices with locations throughout Manhattan, Brooklyn, Queens, Long Island, Westchester County, Rockland County, and New Jersey. SDG currently provides advanced dermatology services to over 250,000 patients annually and offers unique patient benefits including same-day scheduling. Dr. Schweiger’s vision is to make top-notch dermatology services easily accessible in the Tri-State area by opening new practices and revitalizing existing practices throughout the metro New York City area.
Dr. Schweiger is frequently called upon by the media to lend his expertise on cosmetic dermatology and has been featured in numerous publications, including Harpers Bazaar, Marie Claire, In Style, The New York Times, The Wall Street Journal, Glamour, Cosmopolitan, Dr. Oz The Good Life and Allure. Dr. Schweiger is also a seasoned on-air personality and has appeared on Good Morning America, Fox News, Dr. Steve Show, ABC Eyewitness News, and CBS’s The Couch.
American Board of Dermatology
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
NYU Medical Center
University of Kansas Medical Center
Schweiger es, Kwasniak l, Aires dj. Treatment of Dermatosis Papulosa Nigra with a 1064 nm Nd:YAG laser: Report of 2 Cases. Journal of Cosmetic and Laser Therapy 2008 June; 10(2).
Schweiger es. Dalbavancin: a viewpoint by Eric S. Schweiger. Drugs 2008; 68(5).
Schweiger es, Riddle cc, Aiires dj. Successful Treatment with Injected Hyaluronic acid in a Patient with Lip Assymetry after Surgical Correction of Cleft-lip. Dermatologic Surgery 2008 May; 34 (5).
Amin k, Riddle cc, Aires dj, Schweiger es. Common and alternate oral antibiotic therapies for acne vulgaris: A Review. Journal of Drugs in Dermatology 2007 September; 6(9).
Schweiger es, Riddle cc, Wernli b, Tonkovic-Capin v. Comparison of Poly-L-Lactic Acid and Calcium Hydroxylapatite for the Treatment of Human Immunodeficiency Virus-Associated Lipoatrophy. Cosmetic Dermatology 2007 May; 20(5).
Riddle cc, Amin k, Schweiger es. Review of Azithromycin for the Treatment of Acne Vulgaris. Cosmetic Dermatology 2007 May; 20(5).
Schweiger e, Spann ct, Weinberg jm, Ross b. A Case of Desmoplastic Trichilemmoma of the Lip Treated with Mohs Surgery. Dermatologic Surgery 2004 Jul; 30(7).
Garzon mc, Schweiger e. Cutis Marmorata Telangiectatica Congenita. Seminars in Cutaneous Medicine and Surgery 2004 June; 23(2).
Schweiger es, Weinberg jm. Novel antibacterial agents for skin and skin structure infections. Journal of the American Academy of Dermatology 2004 March; 50(3).
Schweiger es, Scheinfeld ns, Tishler hr, Weinberg jm. Linezolid and Quinupristin/Dalfopristin: Novel antibiotics for gram-positive infections of the skin. Journal of Drugs in Dermatology 2003 Aug; 2(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Schweiger is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.